首页 > 资讯 > Ypsomed和Sidekick Health推出了一项针对肥胖管理的协作数字健康解决方案

Ypsomed和Sidekick Health推出了一项针对肥胖管理的协作数字健康解决方案

泰然健康网
2025-07-14 15:04

/PRNewswire/ --

Ypsomed and Sidekick Health are launching an integrated digital health solution to better support people with obesity. Ypsomed's autoinjectors seamlessly integrate into Sidekick's digital health and chronic condition support app to help patients using GLP-1-based injectable therapies manage their treatment more effectively..

Ypsomed 和 Sidekick Health 推出了一项集成的数字健康解决方案，以更好地支持肥胖症患者。Ypsomed 的自动注射器无缝集成到 Sidekick 的数字健康与慢性病支持应用程序中，帮助使用基于 GLP-1 的注射疗法的患者更有效地管理他们的治疗。

In this digital health solution the SmartPilot, an intelligent add-on for YpsoMate autoinjectors, is paired with the Sidekick app. This allows users, medical professionals, and pharma companies to see real-time injection data on time and date, duration, and correctness of administration, while simultaneously supporting users with wrap-around disease education and selfcare support..

在此数字健康解决方案中，智能附件SmartPilot与YpsoMate自动注射器配合使用，并与Sidekick应用程序配对。这使得用户、医疗专业人员和制药公司能够实时查看注射数据，包括时间、日期、持续时间和注射的正确性，同时为用户提供全面的疾病教育和自我护理支持。

The challenge of obesity: support for a complex chronic condition

肥胖症的挑战：对复杂慢性病的支持

Obesity is a complex, multifaceted chronic condition that demands holistic care and affects hundreds of millions of people worldwide. Despite the transformative potential of GLP-1 therapies, many patients struggle with selfcare-management. They face challenges such as managing side effects, understanding their condition, and adhering to medication titration schedules.

肥胖症是一种复杂的、多方面的慢性疾病，需要整体护理，影响着全球数亿人。尽管GLP-1疗法具有变革性的潜力，但许多患者在自我护理管理方面仍面临困难。他们面临的挑战包括管理副作用、理解自身病情以及遵循药物调整计划等。

As a result, many fail to reach their therapeutic potential, which limits the effectiveness of GLP-1 therapies..

因此，许多药物未能达到其治疗潜力，这限制了 GLP-1 疗法的有效性。

A tailored digital solution for obesity management

量身定制的肥胖管理数字解决方案

By improving adherence and persistence, this integrated solution aims to unlock the full health potential of GLP-1 therapies, including sustained weight loss, and reductions in cardiovascular and metabolic risks.

通过提高依从性和持久性，这一综合解决方案旨在充分释放GLP-1疗法的健康潜力，包括持续减重以及降低心血管和代谢风险。

Key features include:

主要特点包括：

Resources to help patients better understand obesity as a condition, manage medication titration, and set realistic expectations for treatment outcomes.

帮助患者更好地了解肥胖作为一种疾病、管理药物调整以及设定对治疗结果的现实期望的资源。

Lifestyle and behavioral support:

生活方式和行为支持：

Personalised, engaging content based on behavioral health principles to empower patients throughout their treatment journey, including symptom tracking, nutritional guidance, physical activity coaching, and tools to enhance sleep, and manage stress.

基于行为健康原则的个性化、吸引人的内容，旨在治疗旅程中赋予患者能力，包括症状跟踪、营养指导、体育活动辅导以及增强睡眠和管理压力的工具。

: A dedicated injection guide designed to simplify and optimise the injection process, including a reminder function, step-by-step instructions, feedback on whether the injection has been conducted correctly, and addressing needle-related concerns.

：一份专门的注射指南，旨在简化和优化注射过程，包括提醒功能、分步说明、对注射是否正确执行的反馈，以及解决与针头相关的问题。

The solution offers a robust technical platform for pharmaceutical companies to deliver an enhanced patient experience by integrating therapy and injection procedures while supporting patient behavior tracking. Ypsomed's smart devices collect real-time adherence data, generating high-quality real-world data to optimise therapy..

该解决方案为制药公司提供了一个强大的技术平台，通过整合治疗和注射流程来提升患者的体验，同时支持患者行为追踪。Ypsomed的智能设备收集实时依从性数据，生成高质量的真实世界数据以优化治疗。

'This collaboration with Sidekick Health enables us to empower patients with knowledge, real-time insights and smarter therapy management, improving long-term health outcomes. By connecting our smart injection devices, real-time data can be collected to track therapy. This allows our pharma customers to continually improve the treatment of obesity,' said Ulrike Bauer, Chief Business Officer of Ypsomed Delivery Systems..

“与Sidekick Health的合作使我们能够通过知识、实时洞察和更智能的治疗管理来赋能患者，改善长期健康结果。通过连接我们的智能注射设备，可以收集实时数据来跟踪治疗情况。这使我们的制药客户能够不断改进肥胖症的治疗，”Ypsomed Delivery Systems首席商务官Ulrike Bauer表示。

'This partnership exemplifies our commitment to leveraging technology to address critical gaps in chronic condition management. Our partnership with Ypsomed underscores our shared commitment to transforming the treatment journey for people with obesity and enhancing patient outcomes,' said Dr.

“这种合作关系体现了我们致力于利用技术来解决慢性病管理中的关键空白。我们与Ypsomed的合作强调了我们共同致力于改变肥胖症患者的治疗过程并提高患者疗效，”博士表示。

Tryggvi Thorgeirsson

特里格维·索尔吉尔松

, CEO of Sidekick Health.

，Sidekick Health的首席执行官。

For more details on this collaboration and how digital health enhances the management of chronic conditions, visit

有关此合作的更多详情以及数字健康如何加强慢性病管理，请访问

https://yds.ypsomed.com/en/digital-health/therapy-management.html

https://yds.ypsomed.com/zh/数字健康/治疗管理.html

, Sidekick Health

，Sidekick Health

+1 212 930 8555

press@sidekickhealth.com

Sidekick Health is a digital health and therapeutics innovator founded by two passionate medical doctors on a mission to improve the health of humanity. ‍Sidekick provides a uniquely wide range of digital health programs (including oncology, cardiovascular, metabolic, inflammatory, and other chronic conditions), engaging and empowering people to make positive changes, and improve their health outcomes and quality of life.

Sidekick Health 是由两位充满热情的医生创立的数字健康和治疗创新者，致力于改善人类健康。Sidekick 提供范围极广的数字健康计划（包括肿瘤学、心血管、代谢、炎症及其他慢性疾病），吸引并赋予人们积极改变的力量，从而改善他们的健康结果和生活质量。

Sidekick works with health insurers, including leading national US health plans, and pharmaceutical companies, including half of the 10 leading Life Sciences companies, to improve patient outcomes, drive clinical efficiency, and lower the cost of care. To learn more, visit .

Sidekick与健康保险公司（包括美国领先的国家健康计划）和制药公司（包括十大生命科学公司中的一半）合作，以改善患者治疗效果、提高临床效率并降低护理成本。欲了解更多信息，请访问。

www.sidekickhealth.com

https://mma.prnewswire.com/media/2242201/5251877/Sidekick_Health_Logo.jpg

WANT YOUR COMPANY'S NEWS

想要贵公司的新闻

FEATURED ON PRNEWSWIRE.COM?

荣登PRNEWSWIRE.COM？